Helicobacter Infections: Clinical Trials

9 trials for Helicobacter Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 1 recruiting, 1 terminated. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Unknown 4, Completed 3, Recruiting 1, Terminated 1
Phase 22Completed 1, Unknown 1

Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.
Minocycline, Keverprazan, Amoxicillin - Helicobacter Infection
Phase 3RecruitingNanjing First Hospital, Nanjing Medical University6122026-07-152026-11-05
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
Rifabutin, Amoxicillin, Esomeprazole - Helicobacter Infections, Resistance Bacterial
Phase 3UnknownRabin Medical Center3002021-05-012021-03-10
A Unique Regimen for Treatment of Helicobacter Pylori Infection
Quadruple therapy, Classic treatment - Helicobacter Infections
Phase 3UnknownSherief Abd-Elsalam6002018-04-012018-04-10
Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion
Pylopass, Placebo - HELICOBACTER INFECTION
Phase 2 / Phase 3CompletedAtlantia Food Clinical Trials242014-01-012015-01-15
Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy
Omeprazole, amoxicillin, clarithromycin, Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole - Helicobacter Infections
Phase 3CompletedForest Laboratories4402008-06-012017-03-16
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
clartihromycin, amoxicillin, and omeprazole, placebo - Parkinson's Disease, Helicobacter Infections
Phase 3TerminatedUniversity of California, Los Angeles642008-01-012017-12-02
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Quadruple sequential Helicobacter pylori eradication + iron sulfate, Quadruple sequential Helicobacter pylori eradication therapy, Ferrous sulfate - Iron Deficiency
Phase 3CompletedThe University of Texas Health Science Center, Houston1252007-03-012009-06-30
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis
Phase 2 / Phase 3UnknownHamamatsu University2003-08-012006-03-21
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Lansoprazole, clarithromycin, amoxicillin - Helicobacter Infections, Gastritis
Phase 3UnknownHamamatsu University2962003-04-012006-09-11

Narrower conditions

Duodenal Ulcer (2)  ·  Gastritis (2)  ·  Stomach Ulcer (2)  ·  Iron Deficiencies (1)  ·  Parkinson Disease (1)

Broader conditions

Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Negative Bacterial Infections (9)  ·  Infections (9)  ·  Digestive System Diseases (2)  ·  Duodenal Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Peptic Ulcer (2)  ·  Stomach Diseases (2)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Iron Metabolism Disorders (1)

Interventions

Amoxicillin (6)  ·  Clarithromycin (5)  ·  Metronidazole (2)  ·  Omeprazole (2)  ·  Esomeprazole (1)  ·  Iron-Dextran Complex (1)  ·  Lansoprazole (1)  ·  Minocycline (1)  ·  Rabeprazole (1)  ·  Rifabutin (1)  ·  Tetracycline (1)  ·  Tinidazole (1)  ·  ferrous sulfate (1)

Sponsors

Hamamatsu University (2)  ·  Atlantia Food Clinical Trials (1)  ·  Forest Laboratories (1)  ·  Nanjing First Hospital, Nanjing Medical University (1)  ·  Rabin Medical Center (1)  ·  Sherief Abd-Elsalam (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of California, Los Angeles (1)

Countries

Japan (2)  ·  United States (2)  ·  China (1)  ·  Egypt (1)  ·  Ireland (1)  ·  United Kingdom (1)

Top investigators

Asem Elfert, Prof (1)  ·  Ayman Yousry, Prof (1)  ·  Doron Boltin, MBBS (1)  ·  Hussein A Elamin, Prof (1)  ·  Jeff M Bronstein, MD, PhD (1)  ·  Martin JM Buckley, MRCPI, FRCPI (1)  ·  Mohamed Adel Elbasiony, MD (1)  ·  Mohamed Alboraie, MD (1)  ·  Naohito Shirai, MD., PhD (1)  ·  Sherief Abd-Elsalam, MD (1)  ·  Takahisa Furuta, MD, PhD (1)  ·  Victor M Cardenas, MD, MPH, PhD (1)  ·  Walied El-Hossary, MD (1)

Results publications

PMID 11197288, PMID 16441468, PMID 21336156, PMID 21336159, PMID 21345487, PMID 32153909, PMID 32365359, PMID 33037845